Instruction for use: Methyldioxotetrahydropyrimidine sulfonisonicotinoyl hydraside

Trade name of the drug – Tubosan

The Latin name of the substance Methyldioxotetrahydropyrimidine sulfonisonicotinoyl hydraside

Methyldioxotetrahydropyrimidini sulfonisonicotinoyli hydrasidum (genus. Methyldioxotetrahydropyrimidini sulfonisonicotinoyli hydrasidi)

Pharmacological group of substances Methyldioxotetrahydropyrimidine sulfonisonicotinoyl hydraside

Other immunomodulators

Model clinical-pharmacological article 1

Pharmacotherapy. Immunostimulating agent, affects all parts of the immune system; Is active against mycobacteria tuberculosis, leprosy (including resistant forms), herpes viruses.

Pharmacokinetics. TCmax - 6 hours, therapeutic concentration is maintained for 12-18 hours. It is excreted through the gastrointestinal tract - 50%.

Indication. Diseases on the background of a secondary immunodeficiency state: tuberculosis, leprosy, chlamydia, herpetic infection.

Contraindications. Hypersensitivity, pregnancy, lactation.

Dosing. Inside, 200-400 mg for 30 minutes before or 2 hours after meals. The maximum daily dose is 1.6 g. For acute diseases, the course of treatment is 2-3 weeks; At chronic - 6-12 months.

Side effect. Allergic reactions.

Interaction. Enhances the effect of antibacterial drugs (including macrolides, cephalosporins, aminoglycosides).